OREX Related Hot Upgrades
-
UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space
-
Orexigen Therapeutics (OREX) Surges on BofA Upgrade
-
BofA/Merrill Lynch Upgrades Orexigen Therapeutics (OREX) to Buy
-
BofA/Merrill Lynch Upgrades Orexigen Therapeutics (OREX) to Buy
-
BofA/Merrill Lynch Upgrades Vivus (VVUS) Two-Notches to Buy
Back to OREX Stock Lookup
